These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9779863)

  • 1. A case of Stevens-Johnson syndrome associated with oxaprozin therapy.
    Bell MJ; Bishara LD
    J Rheumatol; 1998 Oct; 25(10):2026-8. PubMed ID: 9779863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: oxaprozin and fatal toxic epidermal necrolysis.
    Paul CN; Voigt DW; Clyne KE; Hansen SL
    J Burn Care Rehabil; 1998; 19(4):321-3. PubMed ID: 9710730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaprozin: a new NSAID.
    al-Faks MA; Pugh MC
    Orthop Rev; 1992 May; 21(5):558, 560-3. PubMed ID: 1603605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaprozin for arthritis.
    Med Lett Drugs Ther; 1993 Feb; 35(890):15-6. PubMed ID: 8426570
    [No Abstract]   [Full Text] [Related]  

  • 6. Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis.
    Emberger M; Lechner AM; Zelger B
    Clin Infect Dis; 2003 Jul; 37(1):e5-7. PubMed ID: 12830430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome associated with oral minoxidil: a case report.
    Callen EC; Church CO; Hernandez CL; Thompson ED
    J Nephrol; 2007; 20(1):91-3. PubMed ID: 17347980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options.
    Allegra A; Alonci A; Penna G; Russo S; Gerace D; Greve B; D'Angelo A; Catena S; Musolino C
    Hematol Oncol; 2012 Mar; 30(1):41-5. PubMed ID: 21702057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis.
    Akula SK; Aruna AS; Johnson JE; Anderson DS
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):187-90. PubMed ID: 9441086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive patch test to diclofenac in Stevens-Johnson syndrome.
    Alonso R; Enrique E; Cisteró A
    Contact Dermatitis; 2000 Jun; 42(6):367. PubMed ID: 10871116
    [No Abstract]   [Full Text] [Related]  

  • 12. Stevens-Johnson syndrome: a case report.
    Shetty SR; Chatra L; Shenai P; Rao PK
    J Oral Sci; 2010 Jun; 52(2):343-6. PubMed ID: 20587964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M; Spivack E; Kerpel SM; Freedman PD
    AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN
    Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric irritation of oxaprozin, a new nonsteroidal, antiinflammatory drug, in comparison to acetylsalicylic acid and indomethacin: a gastric potential difference analysis.
    Lücker PW; Venitz J; Ahrens S; Kaiser PM
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):469-75. PubMed ID: 3683021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management.
    Hazin R; Ibrahimi OA; Hazin MI; Kimyai-Asadi A
    Ann Med; 2008; 40(2):129-38. PubMed ID: 18293143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk].
    Gómez-Criado MS; Ayani I; León-Colombo T; Ramos ML; Reneses MJ
    Rev Neurol; 2004 Jun 1-15; 38(11):1056-60. PubMed ID: 15202085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe case of Stevens-Johnson syndrome in a 11-year-old boy].
    Zabel J; Karaś Z
    Wiad Lek; 1982 May; 35(5):357-60. PubMed ID: 6981258
    [No Abstract]   [Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.